ES432106A1 - Procedimiento para la preparacion de d-homo-20-cetopregna- nos. - Google Patents

Procedimiento para la preparacion de d-homo-20-cetopregna- nos.

Info

Publication number
ES432106A1
ES432106A1 ES432106A ES432106A ES432106A1 ES 432106 A1 ES432106 A1 ES 432106A1 ES 432106 A ES432106 A ES 432106A ES 432106 A ES432106 A ES 432106A ES 432106 A1 ES432106 A1 ES 432106A1
Authority
ES
Spain
Prior art keywords
hydrogen
carbon
see formula
ketopregnanes
homo
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES432106A
Other languages
English (en)
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Schering AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE2360443A external-priority patent/DE2360443A1/de
Priority claimed from DE19742445161 external-priority patent/DE2445161A1/de
Application filed by Schering AG filed Critical Schering AG
Publication of ES432106A1 publication Critical patent/ES432106A1/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J63/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms
    • C07J63/008Expansion of ring D by one atom, e.g. D homo steroids
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P33/00Preparation of steroids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Steroid Compounds (AREA)
ES432106A 1973-11-30 1974-11-20 Procedimiento para la preparacion de d-homo-20-cetopregna- nos. Expired ES432106A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE2360443A DE2360443A1 (de) 1973-11-30 1973-11-30 D-homo-20-ketopregnane
DE19742445161 DE2445161A1 (de) 1974-09-19 1974-09-19 D-homo-20-ketopregnane ii

Publications (1)

Publication Number Publication Date
ES432106A1 true ES432106A1 (es) 1976-11-01

Family

ID=25766200

Family Applications (1)

Application Number Title Priority Date Filing Date
ES432106A Expired ES432106A1 (es) 1973-11-30 1974-11-20 Procedimiento para la preparacion de d-homo-20-cetopregna- nos.

Country Status (14)

Country Link
US (1) US4045574A (en:Method)
JP (1) JPS5084561A (en:Method)
AT (1) AT347611B (en:Method)
CA (1) CA1030522A (en:Method)
CH (1) CH618183A5 (en:Method)
DD (1) DD115659A5 (en:Method)
DK (1) DK134348C (en:Method)
ES (1) ES432106A1 (en:Method)
FR (1) FR2253512B1 (en:Method)
GB (1) GB1494097A (en:Method)
IE (1) IE40423B1 (en:Method)
IL (1) IL46153A (en:Method)
NL (1) NL7415577A (en:Method)
SE (1) SE408426B (en:Method)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4879316A (en) * 1987-02-26 1989-11-07 The University Of Tennessee Research Corporation Interpenetrating polymer network ion exchange membranes and method for preparing same
US6787530B1 (en) 1996-08-23 2004-09-07 Monash University Use of pregnane-diones as analgesic agents
US20070066579A1 (en) * 2002-08-16 2007-03-22 White Michael J 5-androsten-3beta-ol steroid intermediates and processs for their preparation
ATE339437T1 (de) * 2002-08-16 2006-10-15 Pharmacia & Upjohn Co Llc 5-androsten-3-olsteroidzwischenprodukte und verfahren zu deren herstellung
RS60420B1 (sr) 2013-04-17 2020-07-31 Sage Therapeutics Inc 19-nor neuroaktivni steroidi za metode lečenja
WO2014169836A1 (en) 2013-04-17 2014-10-23 Sage Therapeutics, Inc. 19-nor neuroactive steroids and methods of use thereof
SI2986623T1 (sl) 2013-04-17 2019-03-29 Sage Therapeutics, Inc. 19-NOR C3,3-disubstituirani C21-N-pirazolil steroidi in metode njhove uporabe
WO2014169831A1 (en) 2013-04-17 2014-10-23 Sage Therapeutics, Inc. 19-nor c3,3-disubstituted c21-c-bound heteroaryl steroids and methods of use thereof
PT3021852T (pt) 2013-07-19 2021-04-21 Sage Therapeutics Inc Esteroides neuroativos, composições e utilizações das mesmas
JP6466942B2 (ja) 2013-08-23 2019-02-06 セージ セラピューティクス, インコーポレイテッド 向神経活性ステロイド、組成物、及びその使用
WO2015195962A1 (en) 2014-06-18 2015-12-23 Sage Therapeutics, Inc. Neuroactive steroids, compositions, and uses thereof
MX384728B (es) 2014-10-16 2025-03-14 Sage Therapeutics Inc Composiciones para el tratamiento de trastornos del snc.
LT3206493T (lt) 2014-10-16 2020-08-25 Sage Therapeutics, Inc. Kompozicijos ir būdai, skirti cns sutrikimams gydyti
HUE049014T2 (hu) 2014-11-27 2020-09-28 Sage Therapeutics Inc Készítmények és módszerek a központi idegrendszer rendellenességeinek kezelésére
WO2016123056A1 (en) 2015-01-26 2016-08-04 Sage Therapeutics, Inc. Compositions and methods for treating cns disorders
EP3258939B1 (en) 2015-02-20 2022-09-07 Sage Therapeutics, Inc. Neuroactive steroids, compositions, and uses thereof
DK3481844T3 (da) 2016-07-11 2024-07-22 Sage Therapeutics Inc C7, C12 og C16 substituerede neuroaktive steroider og disses fremgangsmåder til anvendelse
IL264129B2 (en) 2016-07-11 2024-05-01 Sage Therapeutics Inc C20, C17 and C21 converted neuroactive steroids and methods of using them
BR112020012761A2 (pt) * 2017-12-22 2021-02-17 Sage Therapeutics, Inc. composições e métodos para o tratamento de distúrbios do snc
CN113383004A (zh) 2018-12-05 2021-09-10 萨奇治疗股份有限公司 神经活性类固醇及其使用方法
CN111410678B (zh) 2019-01-08 2023-02-28 成都康弘药业集团股份有限公司 甾体类化合物、用途及其制备方法
EP3976628A1 (en) 2019-05-31 2022-04-06 Sage Therapeutics, Inc. Neuroactive steroids and compositions thereof
CA3143545A1 (en) * 2019-06-27 2020-12-30 Sage Therapeutics, Inc. Compounds for treating cns disorders
AU2020304673A1 (en) * 2019-06-27 2022-01-20 Sage Therapeutics, Inc. Compositions and methods for treating CNS disorders

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2860158A (en) * 1954-10-18 1958-11-11 Sterling Drug Inc Compounds of the perhydrochrysene series and preparation thereof
US3686223A (en) * 1968-12-26 1972-08-22 Sterling Drug Inc D-homoestratrienes
US3833621A (en) * 1972-03-20 1974-09-03 Richardson Merrell Inc 3-keto-7(alpha,beta)-loweralkyl-delta5 steroids and process for preparing same

Also Published As

Publication number Publication date
DK134348B (da) 1976-10-25
ATA950774A (de) 1978-05-15
US4045574A (en) 1977-08-30
IL46153A0 (en) 1975-02-10
SE7414960L (en:Method) 1975-06-02
FR2253512B1 (en:Method) 1978-02-03
DK604174A (en:Method) 1975-07-28
AU7586774A (en) 1976-06-03
AT347611B (de) 1979-01-10
DD115659A5 (en:Method) 1975-10-12
DK134348C (da) 1977-03-21
IL46153A (en) 1979-01-31
JPS5084561A (en:Method) 1975-07-08
SE408426B (sv) 1979-06-11
CA1030522A (en) 1978-05-02
IE40423L (en) 1975-05-30
IE40423B1 (en) 1979-05-23
NL7415577A (nl) 1975-06-03
GB1494097A (en) 1977-12-07
FR2253512A1 (en:Method) 1975-07-04
CH618183A5 (en:Method) 1980-07-15

Similar Documents

Publication Publication Date Title
ES432106A1 (es) Procedimiento para la preparacion de d-homo-20-cetopregna- nos.
ES448188A1 (es) Un procedimiento para la preparacion de acido lactico.
ES439720A1 (es) Procedimiento para la preparacion de 18-metil-19-nor-20-ce- topregnanos.
ES366943A1 (es) Procedimiento para la preparacion de derivados de 1-etil-3,3-dimetil-ciclohexano.
ES398036A1 (es) Procedimiento para la obtencion de derivados del acido 2- fosfono-butano-1,2-dicarboxilico.
GB1454489A (en) Paromomycin derivatives
ES441784A1 (es) Procedimiento para la preparacion de 7-hidroxi-estradioles.
ES429959A1 (es) Procedimiento para la preparacion de nuevos compuestos analogos de acidos prostanoicos, no presentes en la naturaleza
ES402608A1 (es) Procedimiento para el desdoblamiento de racematos de d, 1- fenilpropanolamina con acidos opticamente activos.
ES432479A1 (es) Procedimiento para la preparacion de esteres dialcohilicos de acido malonico.
ES430369A1 (es) Procedimiento para la preparacion de d-homoesteroides.
ES400056A1 (es) Procedimiento para la preparacion de nuevos 16 alfa, 16 al-fa-metilenesteroides.
ES412799A1 (es) Un procedimiento para preparar alcoholes alcohilsulfonilme-tilbencilicos.
ES428228A1 (es) Procedimiento para la preparacion de 8alfa-estratrienos.
ES425430A1 (es) Procedimiento para la preparacion de derivados de biciclo- alcano.
ES386553A1 (es) Procedimiento de preparacion de un nuevo derivado papavero-linico.
ES394667A1 (es) Procedimiento de preparacion de derivados del acido prosta-noico.
ES453133A1 (es) Procedimiento para la preparacion de 12-epi-digoxina y sus derivados.
ES406542A1 (es) Procedimiento para la preparacion de nuevos cardenolidgli- cosidos.
ES446837A1 (es) Procedimiento para la preparacion de sales de ester dimeti- laminoetilico de acido para-clorofenoxiacetico.
GB991474A (en) Novel steroid compounds and their preparation
ES423976A1 (es) Procedimiento para la preparacion de nuevas bencilaminas.
ES316644A1 (es) Metodo para formar un derivado con contenido de oxigeno de un compuesto insaturado.
ES390920A1 (es) Procedimiento para la preparacion de 4,5 alfa - oxido - gufa-20,22-dienolid-3-(ramnosido 2'83' - dialcohilortocarbo-natos).
ES446110A1 (es) Procedimiento para la preparacion de 10alfa, 11alfa-metilen-prostaglandinas.